- Design
- Systematic review and meta-analysis of controlled cohort studies
- Population
- 9 cohorts, 134,598 adults: 28,625 with chronic hypoparathyroidism
- Primary outcome
- Major cardiovascular events
- Effect
- MI HR 1.19 (1.06 to 1.35), I² = 0%; other outcomes heterogeneous
A meta-analysis pooled nine controlled cohort studies of 134,598 people — 28,625 with chronic hypoparathyroidism and 105,973 without — to estimate cardiovascular risk.
Hypoparathyroidism was associated with a higher hazard of myocardial infarction (HR 1.19, 95% CI 1.06 to 1.35), consistent across studies. Pooled associations with heart failure (HR 1.46), arrhythmia (1.45), stroke (1.24) and all-cause death (1.40) were statistically significant but heterogeneous, and their prediction intervals crossed no effect.
The usual treatment — calcium and active vitamin D — itself raises calcium-phosphate product and urinary calcium, which may contribute to vascular and kidney harm, though these cohorts cannot separate disease from treatment. Kidney stones, nephrocalcinosis and CKD are recognised complications that nephrologists already see. The practical point is that cardiovascular risk deserves the same attention as calcium levels in these patients.
- Assess cardiovascular risk factors formally in adults with chronic hypoparathyroidism
- Aim for low-normal serum calcium and avoid hypercalciuria when titrating calcium and active vitamin D
- Monitor phosphate, urinary calcium and eGFR regularly
- Screen for kidney stones and nephrocalcinosis where symptoms or rising creatinine suggest them
Why it matters
Care for hypoparathyroidism often focuses on calcium levels alone and misses vascular and kidney risk.
Don't overread it
These are observational associations; only the heart attack signal held up across studies, and the cause may be treatment as much as disease.
The statistics, in plain English
A prediction interval estimates the range of effects a new study might find. When it crosses 1.0, as it did for heart failure, stroke and death here, a future study could reasonably find no association.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for nephrology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free